David Guttmann
Papers
1
Total Citations
2
H-Index
1
About
David Guttmann is a clinician-scientist whose research focuses on the intersection of radiation oncology and head and neck cancer, with a particular emphasis on human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC). His major contributions center on refining prognostic models for patients undergoing transoral robotic surgery (TORS), specifically identifying how margin status, lymphovascular invasion, and the number of involved neck levels predict distant failure in p16-positive OPSCC. This work, published in 2018, has been cited 2 times and provides critical guidance for tailoring adjuvant therapy and surveillance strategies in this increasingly common patient population. Guttmann’s research bridges surgical and radiation oncology, helping to define which patients may benefit from more aggressive treatment intensification versus de-escalation. His findings have practical implications for reducing overtreatment and improving outcomes in HPV-related head and neck cancers. Through his focused investigations, Guttmann contributes to the growing body of evidence that personalizes care for patients with OPSCC, highlighting the importance of integrating pathological risk factors into clinical decision-making.
Research Focus
Key Achievements
Top Papers
- 1